Fabienne Ory-Magne

15PUBLICATIONS
56CO-AUTHORS
Pharmaceutical delivery technologiesPhysiotherapyToxicology (incl. clinical toxicology)Neurology and neuromuscular diseasesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 29, 2025
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK).

Olivier Rascol, Fabienne Ory-Magne, Wassilios G Meissner

|Jul 28, 2025
Effect of foot reflexology on chronic pain in Parkinson's disease: A randomized controlled trial.

Karel Joineau, Estelle Harroch, Mathilde Boussac

|Jul 17, 2025
Subcutaneous Apomorphine Infusion Initiation Is Associated with Impulse Control Disorder Attenuation in Advanced Parkinson's Disease Patients: Insights from the French NS-Park Cohort.

Clément Desjardins, Paulo André Dias Bastos, Aymeric Lanore

|Jun 28, 2025
Neuropathy in GAA-FGF14 Late-Onset Cerebellar Ataxia (SCA27B): Prevalence and Characteristics.

Julian Theuriet, Lukas Paulet, Blandine Acket

|Jun 27, 2025
Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's disease.

Mathilde Boussac, Florent Faggianelli, Estelle Harroch

|Jun 08, 2024
Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA Trial.

Christine Brefel-Courbon, Estelle Harroch, Ana Marques

Pageof 3

Frequent Collaborators

5 joint publications

Margherita Fabbri

5 joint publications

Olivier Rascol

4 joint publications

Christine Brefel-Courbon

3 joint publications

Ana-Raquel Marques